UNITED THERAPEUTICS Corp Quarterly Goodwill in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
UNITED THERAPEUTICS Corp quarterly Goodwill history and growth rate from Q4 2010 to Q4 2023.
  • UNITED THERAPEUTICS Corp Goodwill for the quarter ending December 31, 2023 was $33.7M, a 20.4% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $33.7M +$5.7M +20.4% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $28M $0 0% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $28M $0 0% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $28M $0 0% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $28M $0 0% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $28M $0 0% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $28M $0 0% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $28M $0 0% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $28M $0 0% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $28M $0 0% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $28M $0 0% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $28M -$3.5M -11.1% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $28M -$3.5M -11.1% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $28M -$3.5M -11.1% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $28M -$300K -1.06% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $31.5M Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $31.5M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $31.5M +$17.8M +130% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $28.3M +$14.6M +107% Sep 30, 2018 10-Q 2018-10-31
Q4 2017 $13.7M +$3.4M +33% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $13.7M +$3.4M +33% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $13.7M +$3.4M +33% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $10.3M $0 0% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $10.3M $0 0% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $10.3M +$36K +0.35% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $10.3M +$36K +0.35% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $10.3M +$36K +0.35% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $10.3M +$36K +0.35% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $10.3M -$98K -0.95% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $10.3M -$402K -3.77% Jun 30, 2015 10-Q 2015-07-28
Q1 2015 $10.3M -$435K -4.07% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $10.3M -$439K -4.1% Dec 31, 2014 10-K 2016-02-25
Q3 2014 $10.4M -$264K -2.48% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $10.7M +$201K +1.92% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 $10.7M +$295K +2.84% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $10.7M +$173K +1.64% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $10.6M +$210K +2.02% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $10.5M -$213K -2% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $10.4M -$514K -4.71% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $10.5M +$2.41M +29.6% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $10.4M +$4.43M +73.9% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $10.7M +$8.09M +312% Jun 30, 2012 10-Q 2012-07-26
Q1 2012 $10.9M Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $8.12M +$5.64M +227% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $5.99M Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $2.59M Jun 30, 2011 10-Q 2011-07-28
Q4 2010 $2.49M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.